Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice
Kamini Vijeepallam, Vijayapandi Pandy, Thubasni Kunasegaran, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review
Hazrulrizawati Abd Hamid, Aizi Nor Mazila Ramli, Mashitah M. Yusoff
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 137
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model
Iqra Khalid, Uzma Saleem, Bashir Ahmad, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101994-101994
Open Access | Times Cited: 6
Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey
Rhiannon Bath, Tanner Bucholz, Amy Buros, et al.
Journal of Addiction Medicine (2019) Vol. 14, Iss. 3, pp. 244-252
Open Access | Times Cited: 49
The Potential for Kratom as an Antidepressant and Antipsychotic.
Lindsay E Johnson, Lilian Balyan, Amy Magdalany, et al.
(2020) Vol. 93, Iss. 2, pp. 283-289
Closed Access | Times Cited: 37
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
A Critical Review of the Neuropharmacological Effects of Kratom: An Insight from the Functional Array of Identified Natural Compounds
Rahni Hossain, Abida Sultana, Manit Nuinoon, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7372-7372
Open Access | Times Cited: 11
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
Hyperpigmentation From Chronic Kratom Use: A Case Report and Review of the Literature
Bryan Tassavor, Chae Young Eun, Olga V. Nikolskaia, et al.
Cureus (2025)
Open Access
Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models
Vijayapandi Pandy, Kamini Vijeepallam
EXPERIMENTAL ANIMALS (2017) Vol. 66, Iss. 4, pp. 417-423
Open Access | Times Cited: 34
Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism
Kamini Vijeepallam, Vijayapandi Pandy, D. Murugan, et al.
Metabolic Brain Disease (2019) Vol. 34, Iss. 6, pp. 1713-1722
Closed Access | Times Cited: 30
Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers
Nur Aziah Hanapi, Nelson Jeng‐Yeou Chear, Juzaili Azizi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves
Rubashiny Veeramohan, Arief Izzairy Zamani, Kamalrul Azlan Azizan, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283147-e0283147
Open Access | Times Cited: 9
Exploring the use of Kratom (Mitragyna speciosa) via the YouTube data tool: A novel netnographic analysis
Elisabeth Prevete, Aleksi Hupli, Shanna Marrinan, et al.
Emerging Trends in Drugs Addictions and Health (2021) Vol. 1, pp. 100007-100007
Open Access | Times Cited: 19
LC/ESI/TOF-MS Characterization, Anxiolytic and Antidepressant-like Effects of Mitragyna speciosa Korth Extract in Diabetic Rats
Lin Chen, Shizao Fei, Opeyemi Joshua Olatunji
Molecules (2022) Vol. 27, Iss. 7, pp. 2208-2208
Open Access | Times Cited: 12
Chemical, pharmacological properties and biosynthesis of opioid mitragynine in Mitragyna speciosa (kratom)
Jorge Jonathan Oswaldo Garza‐García, Yang Qu
Current Opinion in Plant Biology (2024) Vol. 81, pp. 102600-102600
Open Access | Times Cited: 2
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 304-316
Closed Access | Times Cited: 6
Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis
Noah A. Omeiza, Adewale G. Bakre, Halimat Amin Abdulrahim, et al.
Journal of Ethnopharmacology (2022) Vol. 295, pp. 115432-115432
Closed Access | Times Cited: 9
The ethyl acetate fraction of a methanolic extract of unripe noni (<i>Morinda citrifolia</i> Linn.) fruit exhibits a biphasic effect on the dopaminergic system in mice
Vijayapandi Pandy, Megala Narasingam, Kamini Vijeepallam, et al.
EXPERIMENTAL ANIMALS (2017) Vol. 66, Iss. 3, pp. 283-291
Open Access | Times Cited: 10
Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats
Illa Syafiqah Johari, Norsyifa Harun, Zarif Mohamed Sofian, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3183-3191
Closed Access | Times Cited: 9
Albizia zygia root extract exhibits antipsychotic-like properties in murine models of schizophrenia
Victor Kumbol, Wonder Kofi Mensah Abotsi, Edmund Ekuadzi, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 831-841
Closed Access | Times Cited: 9
Synthesis of spiro[indolizidine-1,3′-oxindole] from l-glutamic acid
Punlop Kuntiyong, Nantachai Inprung, Kunita Phakdeeyothin, et al.
Tetrahedron (2020) Vol. 76, Iss. 24, pp. 131261-131261
Closed Access | Times Cited: 8
Kratom as a novel cause of photodistributed hyperpigmentation
Landon R. Powell, Ted J. Ryser, Gabriel Morey, et al.
JAAD Case Reports (2022) Vol. 28, pp. 145-148
Open Access | Times Cited: 5
Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone
Aimee N. Jensen, Quynh-Nhu Truong, Melanie Jameson, et al.
Mental Health Clinician (2021) Vol. 11, Iss. 3, pp. 220-224
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top